HEALTH● ELEVATEDJul 14 · Jul 14, 2026, 10:31 PM
WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola
France 24 [en]
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH13m agoCDC deputy director to leave administration after 4 monthsThe HillHEALTH34m agoNigeria records 43,000 snakebites, 2,500 deaths yearlyVanguard NigeriaHEALTH1h agoEbola: NCDC defends patient’s evacuation, rejects claims of no confidenceVanguard NigeriaHEALTH1h agoCDC's chief medical officer resigns after being hired in AprilABC News